e-learning
resources
Barcelona 2010
Monday, 20.09.2010
COPD and asthma: models and human studies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Airways renin angiotensin system activation during allergic lung disease
I. L. Dumitriu, B. Gurzu, P. Plamadeala, L. Foia (Iasi, Romania)
Source:
Annual Congress 2010 - COPD and asthma: models and human studies
Session:
COPD and asthma: models and human studies
Session type:
E-Communication Session
Number:
1991
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. L. Dumitriu, B. Gurzu, P. Plamadeala, L. Foia (Iasi, Romania). Airways renin angiotensin system activation during allergic lung disease. Eur Respir J 2010; 36: Suppl. 54, 1991
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Intrapulmonary renin angiotensin activation in antigen-induced airway hyperresponsiveness
Source: Eur Respir J 2007; 30: Suppl. 51, 134s
Year: 2007
Bronchial reactivity for histamine and serum angiotensin converting enzyme (sACE) activity in sarcoidosis patients
Source: Eur Respir J 2004; 24: Suppl. 48, 669s
Year: 2004
Etiology specific reductions in pulmonary endothelial angiotensin converting enzyme activity in patients with PAH
Source: Eur Respir J 2006; 28: Suppl. 50, 658s
Year: 2006
Role of tissue kallikrein 1 in late phase bronchoconstriction and airway hyperresponsiveness
Source: Annual Congress 2006 - Basic mechanisms of allergic airways inflammation
Year: 2006
Allergic lung inflammation induces pulmonary vascular hyperresponsiveness
Source: Eur Respir J 2006; 28: 370-377
Year: 2006
ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin
Source: Eur Respir J 2008; 31: 363-371
Year: 2008
Angiotensin-converting enzyme 2 expression is not induced by the renin–angiotensin system in the lung
Source: ERJ Open Res, 6 (4) 00402-2020; 10.1183/23120541.00402-2020
Year: 2020
HIF-1α inhibitor, 2ME2, attenuates airway inflammation and hyperresponsiveness in allergic airway disease
Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Year: 2008
Ghrelin effects on local renin angiotensin from pulmonary vessels
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011
Autoimmunity in airway inflammation and asthma
Source: International Congress 2017 – GR3 Scientific Grand Round: Autoimmunity in chronic lung disease
Year: 2017
Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015
Evaluation in administration of angiotensin II receptor antagonist Valsartan in the treatment of hypertension patients with chronic obstructive pulmonary disease.
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
Inhibition of the renin-angiotensin system in severe COPD
Source: Eur Respir J 2008; 32: 1128-1129
Year: 2008
Association of circulating angiotensin converting enzyme activity with respiratory muscle function in infants
Source: Annual Congress 2010 - Paediatric and neonatal intensive care
Year: 2010
The increased contractility of idiopathic pulmonary fibrosis lung fibroblasts is dependent on angiotensin signalling
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial
Source: Eur Respir J 2006; 27: 972-979
Year: 2006
Osteopontin blockade prevents fibrosis in a murine chronic model of allergic airway disease
Source: Eur Respir J 2007; 30: Suppl. 51, 60s
Year: 2007
Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice
Source: Eur Respir J 2009; 34: 200-208
Year: 2009
Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis
Source: Eur Respir J 2012; 39: 141-148
Year: 2012
Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis
Source: Eur Respir J 2011; 39: 141-148
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept